Space & Microgravity as an Innovation Platform for R&D

3:00 PM - 4:00 PM (PDT), Wednesday, June 15, 2022 ・ Upper Level, Session Room 5A


Commercial space activity is on the rise with advances in technologies that are lowering barriers for accessing the unique environment only available in low Earth orbit (LEO). These advances have led to increased human spaceflight activity as well as increased demand for on-orbit services. The narrative is now shifting to utilizing space and microgravity as an innovation platform for commercial biomedical applications and advanced materials. This session will focus on how to leverage microgravity and the space environment for discovery research, how to develop new products (such as retinal implants) or improve existing products (such as bioreactors and stem cell manufacturing) in space, and why space is an important business growth strategy to consider for biopharma. You will hear from a scientist at BMS who is using microgravity to enhance drug discovery; an entrepreneur who is using space to manufacture retinal implants; a visionary who is establishing the first CRO in space; and an avid biotech investor turned private astronaut who understands the value of space for biopharma innovation. This session is a must if you're looking to understand what's on the horizon soon as the first commercial space station takes flight in 2024.



Business Development
Axiom Space
Associate Director
Bristol Myers Squibb
Director, Sanford Stem Cell Clinical Center; Director, CIRM Alpha Stem Cell Clinic; Chief, Division
University of California, San Diego
Private Astronaut-in-Training
President and CEO